|The researchers reported no financial conflicts.
The study was supported by the Intramural Research Program at the National Institute of Mental Health, the National Institutes of Health, and the Department of Health & Human Services. Co-author Jaskaran B. Singh, M.D., is currently at Johnson & Johnson Pharmaceutical Research and Development L.L.C.
Primary source: Bipolar Disorders
Source reference: Zarate, Jr. CA, et al "Efficacy of a Protein Kinase C Inhibitor (Tamoxifen) in the Treatment of Acute Mania: A Pilot Study" Bipolar Disorders 2007; Sept. online